AIMC Topic: Drug Design

Clear Filters Showing 201 to 210 of 582 articles

CADD, AI and ML in drug discovery: A comprehensive review.

European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences
Computer-aided drug design (CADD) is an emerging field that has drawn a lot of interest because of its potential to expedite and lower the cost of the drug development process. Drug discovery research is expensive and time-consuming, and it frequentl...

Selective Inhibitor Design for Kinase Homologs Using Multiobjective Monte Carlo Tree Search.

Journal of chemical information and modeling
Designing highly selective molecules for a drug target protein is a challenging task in drug discovery. This task can be regarded as a multiobjective problem that simultaneously satisfies criteria for various objectives, such as selectivity for a tar...

Application of Computational Biology and Artificial Intelligence in Drug Design.

International journal of molecular sciences
Traditional drug design requires a great amount of research time and developmental expense. Booming computational approaches, including computational biology, computer-aided drug design, and artificial intelligence, have the potential to expedite the...

Training recurrent neural networks as generative neural networks for molecular structures: how does it impact drug discovery?

Expert opinion on drug discovery
INTRODUCTION: Deep learning approaches have become popular in recent years in de novo drug design. Generative models for molecule generation and optimization have shown promising results. Molecules trained on different chemical data could regenerate ...

De novo design of anti-tuberculosis agents using a structure-based deep learning method.

Journal of molecular graphics & modelling
Mycobacterium tuberculosis (Mtb) is a pathogen of major concern due to its ability to withstand both first- and second-line antibiotics, leading to drug resistance. Thus, there is a critical need for identification of novel anti-tuberculosis agents t...

Adversarial deep evolutionary learning for drug design.

Bio Systems
The design of a new therapeutic agent is a time-consuming and expensive process. The rise of machine intelligence provides a grand opportunity of expeditiously discovering novel drug candidates through smart search in the vast molecular structural sp...

Drug Design Using Reinforcement Learning with Graph-Based Deep Generative Models.

Journal of chemical information and modeling
Machine learning provides effective computational tools for exploring the chemical space via deep generative models. Here, we propose a new reinforcement learning scheme to fine-tune graph-based deep generative models for molecular design tasks. We ...

Drug-target binding affinity prediction method based on a deep graph neural network.

Mathematical biosciences and engineering : MBE
The development of new drugs is a long and costly process, Computer-aided drug design reduces development costs while computationally shortening the new drug development cycle, in which DTA (Drug-Target binding Affinity) prediction is a key step to s...

Developing Role for Artificial Intelligence in Drug Discovery in Drug Design, Development, and Safety Assessment.

Chemical research in toxicology
Artificial intelligence (AI) is a rapidly growing discipline in the field of chemical toxicology. Herein, we provide a broad overview of research presented at the Fall 2022 American Chemical Society meeting, highlighting how AI is being applied acros...

Deep learning methods for molecular representation and property prediction.

Drug discovery today
With advances in artificial intelligence (AI) methods, computer-aided drug design (CADD) has developed rapidly in recent years. Effective molecular representation and accurate property prediction are crucial tasks in CADD workflows. In this review, w...